WHO ICTRP trial
OLANZAPINE VS LAMOTRIGINE ADD-ON TO LITHIUM:EFFICACY ON ANXIETY SYMPTOMS IN…
EUCTR2005-001606-66-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2005-001606-66-IT |
|---|---|
| Public title | OLANZAPINE VS LAMOTRIGINE ADD-ON TO LITHIUM:EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS |
| Scientific title | OLANZAPINE VS LAMOTRIGINE ADD-ON TO LITHIUM:EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS |
| Primary sponsor | AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS MedDRA version: 6.1 Level: PT Classification code 10057667 |
| Interventions | Trade Name: ZYPREXA VELOTAB*28 CPR 5 MG Pharmaceutical Form: Tablet INN or Proposed INN: Olanzapine CAS Number: 132539-06-1 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 5- Trade Name: LAMICTAL*25MG 28… |
| Registration date | Dec 7, 2005 |
| Secondary IDs | OLZvsLMT-DB |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: